Ardent Health Partners Inc. (ARDT)
NYSE NYSE Primary 
New Strong Sell Stocks for Nov. 18th
DIOD, ARDT and FFIV have been added to the Zacks Rank #5 (Strong Sell) List on November 18, 2025.
Ardent Health, Inc. (ARDT) Q3 2025 Earnings Call Transcript
Ardent Health, Inc. ( ARDT ) Q3 2025 Earnings Call November 13, 2025 9:00 AM EST Company Participants David Styblo - Senior Vice President of Investor Relations Martin Bonick - President, CEO & Director Alfred Lumsdaine - Chief Financial Officer Conference Call Participants Jason Cassorla - Guggenheim Securities, LLC, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Kevin Fischbeck - BofA Securities, Research Division Zach Haggerty Raj Kumar - Stephens Inc., Research Division Craig Hettenbach - Morgan Stanley, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Ardent Health, Inc. (ARDT) Surpasses Q3 Earnings and Revenue Estimates
Ardent Health, Inc. (ARDT) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.19 per share a year ago.
Ardent Health, Inc. (ARDT) Q2 Earnings and Revenues Surpass Estimates
Ardent Health, Inc. (ARDT) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.35 per share a year ago.
Analysts Estimate Ardent Health, Inc. (ARDT) to Report a Decline in Earnings: What to Look Out for
Ardent Health, Inc. (ARDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ardent Health: The Best Prospect In An Industry That's Facing Challenges
Ardent Health faces significant legislative risks, due to Medicaid and Medicare cuts, causing uncertainty and a recent downgrade, but much of this is priced in. Despite headwinds, Ardent Health demonstrates strong revenue and profitability growth, low leverage, and trades at compellingly cheap valuations, versus peers. Management projects continued growth for 2025, with revenue and EBITDA expected to rise, supported by higher-margin service expansions and acquisitions.
Wall Street Analysts Predict a 36.55% Upside in Ardent Health Partners, Inc. (ARDT): Here's What You Should Know
The mean of analysts' price targets for Ardent Health Partners, Inc. (ARDT) points to a 36.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Ardent Health Partners, Inc. (ARDT) Q1 2025 Earnings Call Transcript
Ardent Health Partners, Inc. (NYSE:ARDT ) Q1 2025 Earnings Conference Call May 7, 2025 10:00 AM ET Company Participants David Styblo - Senior Vice President of Investor Relations Marty Bonick - President and Chief Executive Officer Alfred Lumsdaine - Chief Financial Officer Conference Call Participants Whit Mayo - Leerink Partners Ann Hynes - Mizuho Craig Hettenbach - Morgan Stanley Ben Hendrix - RBC Capital Markets Joanna Gajuk - Bank of America Matthew Gillmor - KeyBanc Benjamin Rossi - JPMorgan Operator Ladies and gentlemen, thank you for standing by, and welcome to the Ardent Health Partners First Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, today's call is being recorded.
Ardent Health Partners : releases 2024 Community Impact Report
Ardent Health releases 2024 Community Impact Report [Link]BRENTWOOD, Tenn. (April 2, 2025) - Ardent Health (NYSE: ARDT) has released its 2024 Community Impact Report, highlighting the organization's progress advancing healthcare in growing mid-sized urban communities across the U.S. "I'm proud to share the significant progress we've made over the past year," said Marty Bonick, president and CEO of Ardent. "From enhancing the quality of care in our facilities to giving back to our communities and finding new ways to support our team members, we have positively impacted countless lives." aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); The report provides an in-depth look at Ardent's commitment to improving healthcare services, eliminating barriers to care, and fostering a culture of belonging among its team members. The featured stories spotlight the investments Ardent continues to make in new services and technologies that improve patient outcomes and support caregivers, as well as the ways it is driving positive change in the local communities it serves. Click here to learn more about Ardent's impact. AttachmentsOriginal documentPermalinkDisclaimer Ardent Health Partners Inc. published this content on April 02, 2025, and is solely responsible for the information contained herein. Distributed via , unedited and unaltered, on April 02, 2025 at 15:05 UTC.
Ardent Health falls 6% in lukewarm NYSE debut
Healthcare provider Ardent Health's shares opened 6% below their initial public offering price in their NYSE debut on Thursday, reflecting new investor caution with new listings amid rate cut uncertainties.
Ardent Health prices US IPO below target range to raise $192 mln
Healthcare provider Ardent Health said on Wednesday it has set the pricing of its initial public offering below its targeted range to raise around $192 million.
U.S. IPO Weekly Recap: 2 SPACs Debut In Quiet Post-Holiday Week
Two SPACs debuted this week, and one company completed an uplisting from the OTC. Meanwhile, three IPOs and two SPACs submitted initial filings this past week. After a quiet post-holiday week, the July IPO market is set to bag its first major deals in the week ahead. Street research is expected for one company in the week ahead, and one lock-up period will be expiring.
